Abstract
A Randomized Phase 3 Study, Sinus-52, Evaluating the Efficacy and Safety of Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have